Glucose Intolerance During Pregnancy Associated With Postpartum Cardiovascular Risk
Unregistered User
If this is not your name, click here.
Contact Us | Order Now | Journals | Bookstore | Register a colleague
 
  SEARCH  
News
Bookstore
Medline
The Web
Meetings & Congresses
Complete Doctor's Guide
 


 EXPLORE :
 news  All News
 webcasts All Webcasts
 All cases All Cases
 Meetings All Meetings & Congresses
 Medical All Medical Resources

top





New drugs / indications

English Dictionary

Medical Dictionary

Thesaurus



Warning | Privacy | Awards



 Favourite Journals 

Click here to choose your favourite journals


 Favourite Sites 

Click here to choose your favourite sites


 Languages 



  




Glucose Intolerance During Pregnancy Associated With Postpartum Cardiovascular Risk

CHEVY CHASE, Md -- December 2, 2009 --Women who have gestational glucose intolerance exhibit multiple cardiovascular risk factors as early as 3 months after birth, according to a new study that will be published in the February 2010 issue of The Endocrine Society’s Journal of Clinical Endocrinology & Metabolism (JCEM).

Lead study author Ravi Retnakaran, MD, Mount Sinai Hospital and the University of Toronto, Toronto, Ontario, and colleagues sought to evaluate the relationship between gestational glucose intolerance and postpartum risk of metabolic syndrome. They followed 487 women who underwent oral glucose tolerance testing during pregnancy. Each subject was classified as either having normal glucose tolerance, gestational glucose intolerance, or gestational diabetes. At 3 months post partum, they evaluated the subjects’ cardiometabolic characteristics -- blood pressure, weight, waist measurement, and lipid levels.

Findings support that even mild glucose intolerance during pregnancy predicts an increased likelihood of the metabolic syndrome at 3 months post partum. The presence of cardiovascular risk factors as early as 3 months post partum indicates that these risk factors may be longstanding and contribute to the long-term risk of cardiovascular disease in this patient population.

“The study findings raise the important possibility that women with gestational glucose intolerance and subsequent postpartum metabolic syndrome represent a patient population at particularly high risk for the future development of metabolic and vascular disease,” said Dr. Retnakaran. “Further research with long-term follow-up is needed to address this possibility.”

“Our data also suggests that glucose tolerance screening in pregnancy, as is currently practiced, may provide previously unrecognised insight into a woman’s postpartum cardiovascular risk-factor profile,” said Dr. Retnakaran. “Furthermore, glucose tolerance screening may identify subgroups of young women for whom cardiovascular risk-factor monitoring may be warranted.”

SOURCE: The Endocrine Society

E-mail this page
to a friend or colleague!
To print,
use this version




Any question regarding a medical diagnosis, treatment, referral, drug availability or pricing should be directed to either a licensed physician or to the product's manufacturer.

If you have any technical questions or other concerns about this site, feel free to contact us at webmaster@docguide.com.

All contents Copyright (c) 1995- Doctor's Guide Publishing Limited. All rights reserved.


Employment opportunities | Partnering opportunities